---
title: "2018 ACR/ARHP highlights: could upadacitinib upend the US JAK inhibitor market?"
image: "images/writing/post-20.jpg"
link: "https://www.pharmaceutical-technology.com/comment/upadacitinib-jak-inhibitor-market/"
categories: ['Analyst Insight', 'Conference Review', 'Rheumatology']
draft: false
---